Abstract
McCune in 1936 described a 9-year-old female with precocious puberty, hyperpigmentation of the skin, and hyperthyroidism (McCune and Bruch 1936). In 1937, Albright published a case series of five females with bone disease, areas of hyperpigmentation, and precocious puberty (Albright et al. 1937). McCune-Albright syndrome (MAS) consists of polyostotic fibrous dysplasia, precocious puberty, café au lait spots, and other endocrinopathies secondary to hyperactivity of various endocrine glands. It is a rare disease with an estimated prevalence between 1/100,000 and 1/1,000,000.
References
Akintoye, D. O., Chebli, C., Booher, S., et al. (2002). Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 5104–5112.
Albright, F., Butler, A. M., & Hampton, A. O. (1937). Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. The New England Journal of Medicine, 216, 727–747.
Anand, M. K. N. (2011). Fibrous dysplasia imaging. Medscape Reference. Updated 25 May 2011. Available at: http://emedicine.medscape.com/article/389714-overview
Anitha, N., Leena Sankari, S., Malathi, L., et al. (2015). Fibrous dysplasia-recent concepts. Journal of Pharmacy and Bioallied Sciences, 7(Suppl 1), S171–S172.
Bareille, P., Azcona, C., & Stanhope, R. (1999). Multiple neonatal endocrinopathies in McCune-Albright syndrome. Journal of Paediatrics and Child Health, 35, 315–318.
Benedict, P. H. (1962). Endocrine features in Albright’s syndrome (fibrous dysplasia of bone). Metabolism, 1, 30–45.
Bhansali, A., Sharma, B. S., Sreenivasulu, P., et al. (2003). Acromegaly with fibrous dysplasia: McCune-Albright syndrome-Clinical studies in 3 cases and brief review of literature. Endocrine Journal, 50, 793–799.
Boston, B. A. (2010). Pediatric McCune-Albright syndrome. Medscape Reference. Updated 23 Apr 2010. Available at: http://emedicine.medscape.com/article/923026-overview
Bousson, V., Rey-Jouvin, C., Laredo, J.-D., et al. (2014). Fibrous dysplasia and McCune-Albright syndrome: Imaging for positive and differential diagnoses, prognosis, and follow-up guidelines. European Journal of Radiology, 83, 1828–1842.
Boyce, A. M., & Collins, M. T. (2015). Fibrous dysplasia/McCune-Albright syndrome. GeneReviews. Updated 28 Feb 2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1116/
Cabral, C. E., Guedes, P., Fonseca, T., et al. (1998). Polyostotic fibrous dysplasia associated with intramuscular myxomas: Mazabraud’s syndrome. Skeletal Radiology, 27, 278–282.
Chapurlat, R. D., & Orcel, P. (2008). Fibrous dysplasia of bone and McCune-Albright syndrome. Best Practice & Research. Clinical Rheumatology, 22, 55–69.
Coutant, R., Lumbroso, S., Rey, R., et al. (2001). Macroorchidism due to autonomous hyperfunction of Sertoli cells and Gs alpha gene mutation: An unusual expression of McCune-Albright syndrome in a prepubertal boy. Journal of Clinical Endocrinology and Metabolism, 86, 1778–1781.
Danon, M., Robboy, S. J., Kim, S., et al. (1975). Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. Journal of Pediatrics, 87, 917–921.
De Sanctis, C., Lala, R., & Matarazzo, P. (1999). McCune-Albright syndrome: A longitudinal clinical study of 32 patients. Journal of Pediatric Endocrinology & Metabolism, 12, 817–826.
Dumitrescu, C. E., & Collins, M. T. (2008). McCune-Albright syndrome [Review]. Orphanet Journal of Rare Diseases, 3, 12–23.
Eugster, E. A., Rubin, S. D., Reiter, E. O., et al. (2003). Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: A multicenter trial. Journal of Pediatrics, 143, 60–66.
Ferreira, E. C., Brito, C. C. B., Domingues, R. C., et al. (2010). Whole-body MR imaging for the evaluation of McCune-Albright syndrome. Journal of Magnetic Resonance Imaging, 31, 706–710.
Foster, C. M., Feuillan, P., Padmanabhan, V., et al. (1986). Ovarian function in girls with McCune-Albright syndrome. Pediatric Research, 20, 859–863.
Gross, C. W., & Montgomery, W. W. (1967). Fibrous dysplasia and malignant degeneration. Archives of Otolaryngology, 85, 97–101.
Gurler, T., Alper, M., & Gencosmanoglu, R. (1998). McCune-Albright syndrome progressing with severe fibrous dysplasia. The Journal of Craniofacial Surgery, 9, 79–82.
Harris, W. H., Dudley, H. R., & Barry, R. J. (1962). The natural history of fibrous dysplasia, an orthopaedic, pathologic and roentgenographic study. Journal of Bone and Joint Surgery, 44, 207–233.
Isaia, G. C., Lala, R., Defilippi, C., et al. (2002). Bone turnover in children and adolescents with McCune-Albright syndrome treated with Pamidronate for bone fibrous dysplasia. Calcified Tissue International, 71, 121–128.
Lee, P. A., Van Dop, C., & Migeon, C. J. (1986). McCune-Albright syndrome. Long-term follow-up. Journal of the American Medical Association, 256, 2980–2984.
McCune, D. J., & Bruch, H. (1936). Osteodystrophia fibrosa: Report of a case in which the condition was combined with precocious puberty, pathologic pigmentation of the skin and hyperthyroidism, with a review of the literature. American Journal of Diseases of Children, 54, 806–848.
Muthusamy, S., Conway, S. A., & Thomas Temple, H. (2014). Five polyostotic conditions that general orthopedic surgeons should recognize (or should not miss). Orthopedic Clinics of North America, 45, 417–429.
Riminucci, M., Fisher, L. W., Shenker, A., et al. (1997). Fibrous dysplasia of bone in the McCune-Albright syndrome: Abnormalities in bone formation. American Journal of Pathology, 151, 1587–1600.
Shenker, A., Weinstein, L. S., Moran, A., et al. (1993). Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. Journal of Pediatrics, 123, 509–518.
Shenker, A., Weinstein, L. S., & Sweet, D. E. (1994). An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism, 79, 750–755.
Singer, F. R. (1997). Fibrous dysplasia of bone: The bone lesion unmasked. American Journal of Pathology, 151, 1511–1515.
Spiegel, A. M. (1997). The molecular basis of disorders caused by defects in G proteins. Hormone Research, 47, 89–96.
Tinschert, S., Geri, H., & Gewies, A. (1999). McCune-Albright syndrome: Clinical and molecular evidence of mosaicism in an unusual giant patient. American Journal of Medical Genetics, 83, 100–108.
Turan, S., & Bastepe, M. (2015). GNAS spectrum of disorders. Current Osteoporosis Reports, 13, 146–158.
Weinstein, L. S., Shenker, A., Gejman, P. V., et al. (1991). Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. The New England Journal of Medicine, 325, 1688–1695.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Chen, H. (2015). McCune-Albright Syndrome. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6430-3_152-2
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6430-3_152-2
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6430-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
McCune-Albright Syndrome- Published:
- 25 June 2016
DOI: https://doi.org/10.1007/978-1-4614-6430-3_152-3
-
Original
McCune-Albright Syndrome- Published:
- 09 December 2015
DOI: https://doi.org/10.1007/978-1-4614-6430-3_152-2